covid19 drug

Hetero gets DCGI nod to launch biosimilar version of Tocilizumab

by
Hetero gets DCGI nod to launch biosimilar version of Tocilizumab

Hetero’s Tocilizumab 400mg/20ml is the biosimilar version of Roche’s Actemra/RoActemra drug. Tocilizumab is distributed by Cipla in India under licence from Roche. (Representational image) The Drug Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to Hetero for launching a biosimilar version of Tocilizumab, a Covid-19 drug for hospitalised adults. The Hyderabad-based company … Read more

Coronavirus: DRDO’s anti-Covid drug 2-DG receives DCGI approval for emergency use

by
Coronavirus: DRDO’s anti-Covid drug 2-DG receives DCGI approval for emergency use

The second phase trial on average showed that patients administered with the drug recovered 2.5 days earlier than other patients. (Representative image) An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The drug, which was … Read more